Company attributes
Industry
Founder
Pitchbook URL
Legal Name
Cabaletta Bio, Inc.
Date Incorporated
2017
Number of Employees (Ranges)
51 – 200
Email Address
contactus@cabalettabio.com
Phone Number
+1 267 759 3100
Full Address
2929 Arch Street, Suite 600 Philadelphia, PA, 19104, US
Investors
Founded Date
2017
Total Funding Amount (USD)
50,000,000
Latest Funding Round Date
January 2019
Stock Symbol
CABA
Exchange
CFO
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Ticker Symbol
CABA
Cabaletta Bio is a biotechnology company developing cellular therapies for autoimmune diseases that is headquartered in Randor Township, Pennsylvania and was founded in 2017 by Aimee Payne, Michael Milone, and Steven Nichtberger.
What if autoimmune diseases could be cured with a one-time treatment? At Cabaletta Bio, we believe it is possible.
Timeline
No Timeline data yet.
